Clinically meaningful weight loss, defined as a reduction of 5% in baseline BW, was achieved by 73.2%92.4% of semaglutide-treated participants, compared with 21.4%50.0% in the placebo arms [13, 38,39,40,41,42,43,44,45,46]
Research studies on diabetic neuropathy models indicated that glucagon-like peptide-1 receptor agonists, including exenatide, are known to decrease markers of oxidative stress in spinal cord tissues [77]
The chatter on medspa owner groups and patient forums about sourcing research-use-only (RUO) retatrutide is alarming
If you have $2,500 available in your FSA this year, allocating funds to PlexusDx treatment means you're using money that would otherwise face a use-it-or-lose-it deadline